Aplasia cutis congenita and low molecular weight heparin.
Sharif
Saba
S
Academic Unit of Medical Genetics and Regional Genetics Service, Central Manchester and Manchester Children's University Hospitals NHS Trust, UK.
Hay
Charles R M
CR
Clayton-Smith
Jill
J
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000328:Adult; D004476:Ectodermal Dysplasia / Q000139:chemically induced*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000517:prevention & control*; D012536:Scalp Dermatoses / Q000139:chemically induced*; D000078222:Tinzaparin
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D000078222:Tinzaparin